We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

Medical Imaging Technique Enables Accurate Visualization of Tumor-Targeting Bacteria

By MedImaging International staff writers
Posted on 27 Oct 2023
Print article
Image: The new medical imaging technique can observe specialized cancer treatment in breast cancer models (Photo courtesy of 123RF)
Image: The new medical imaging technique can observe specialized cancer treatment in breast cancer models (Photo courtesy of 123RF)

For close to 100 years, science has shown that using particular bacteria to zero in on cancer tumors can help activate the immune system, aiding in cancer treatment. This method has especially been effective in treating bladder cancer while sparing healthy tissues, unlike conventional radiation and chemotherapy. Now, a study to advance the application of such bacterial cancer therapies has led to the development of a new technique to accurately image how these bacterial treatments navigate the body and target breast cancer.

The research team at Johns Hopkins Medicine (Baltimore, MD, USA) had earlier developed an imaging technology that could precisely track bacterial therapies inside the body. This technology involves a molecule known as 18F-Fluorodeoxysorbitol, or 18F-FDS, which bacterial cells readily absorb. Once inside the bacteria, this molecule enables the cells to become visible on PET and CT scans, revealing their location within the body. The team conducted experiments on rodent models with breast cancer, employing their 18F-FDS PET imaging technique. They specifically looked into whether a unique strain of Y. enterocolitica bacteria could target breast cancer tumors and be visualized using their imaging method..

The researchers began by injecting the special Y. enterocolitica strain into mice that had breast cancer. Next, these mice were given an additional injection of the 18F-FDS tracer to get them ready for imaging scans. The mice were then scanned at various time intervals, including days one, five, and ten, using both PET and CT imaging technologies. The scans showed that the Y. enterocolitica strain did effectively target and take up residence in breast cancer tumors. Furthermore, the 18F-FDS tracer enabled precise imaging of where these bacterial cells were located within the mice.

“We are able to use this imaging technology to track the bacteria and make sure the bacterial infection is not sitting in other healthy tissues,” said Sanjay Jain, M.B.B.S., M.D., professor of pediatrics at the Johns Hopkins University School of Medicine. “The technology is helpful in developing these bacterial therapies for cancers, which is what we showed here with the bacteria Yersinia enterocolitica and breast cancer.”

“Being able to use PET imaging to visualize tumor-targeting bacteria will enable faster development and implementation of this innovative tool for oncologic patients,” added Alvaro Ordoñez, M.D., assistant professor of medicine at the Johns Hopkins University School of Medicine.

Related Links:
Johns Hopkins Medicine 

Gold Member
Solid State Kv/Dose Multi-Sensor
Fetal Monitor
Avante Compact II
Pre-Op Planning Solution
Sectra 3D Trauma
1.5T MRI System
uMR 670

Print article


Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.